Skip to Content

Join the 'Hyperlipoproteinemia' group to help and get support from people like you.

Hyperlipoproteinemia Blog

Do Cholesterol Drugs Affect Aggression?

Posted 5 days ago by Drugs.com

WEDNESDAY, July 1, 2015 – Cholesterol-lowering statin drugs might influence a person's aggressive behaviors, increasing or decreasing their irritability and violent tendencies, a new clinical trial suggests. Men taking statins typically become less aggressive, while women on statins tend to become more aggressive, according to findings published July 1 in the journal PLOS ONE. "Clinicians should be aware of this, and it's not bad for patients to be aware of it," said lead author Dr. Beatrice Golomb, a principal investigator at the University of California, San Diego School of Medicine. "If an individual develops a behavioral change, in my view medication should always be considered as a possibility." However, the effect appears to be minimal and needs to be verified with follow-up studies, said one outside expert, Robert Geffner, founding president of the Institute on Violence, Abuse & ... Read more

Related support groups: High Cholesterol, Lipitor, Simvastatin, Crestor, Pravastatin, Atorvastatin, Zocor, Lovastatin, Rosuvastatin, Hypertriglyceridemia, Red Yeast Rice, High Cholesterol - Familial Heterozygous, Livalo, Pravachol, High Cholesterol - Familial Homozygous, Hyperlipoproteinemia Type IIa (Elevated LDL), Hyperlipoproteinemia, Lescol, Lescol XL, Hyperlipoproteinemia Type IIb (Elevated LDL + VLDL)

Half of U.S. Hispanics With High Cholesterol Unaware They Have It: Study

Posted 12 days ago by Drugs.com

WEDNESDAY, June 24, 2015 – Nearly half of Hispanic people in the United States with high cholesterol levels aren't aware they have the health problem and more than two-thirds who are aware aren't being treated, a new study indicates. Reviewing data from more than 16,000 Hispanics between the ages of 18 and 74, the researchers found that about 44 percent of men and 40 percent of women had high cholesterol, greater proportions overall than among the general U.S. population. Almost one-third of all American adults have high levels of low-density lipoprotein (LDL) or "bad" cholesterol, according to the U.S. Centers for Disease Control and Prevention, and less than a third have the condition under control. High cholesterol levels are a major risk factor for developing heart disease or stroke since a build-up of the fatty substance can narrow blood vessels and hinder blood flow to the heart ... Read more

Related support groups: High Cholesterol, Hypertriglyceridemia, High Cholesterol - Familial Heterozygous, High Cholesterol - Familial Homozygous, Hyperlipoproteinemia Type IIa (Elevated LDL), Hyperlipoproteinemia, Hyperlipoproteinemia Type IIb (Elevated LDL + VLDL), Hyperlipoproteinemia Type III (Elevated beta-VLDL + IDL), Hyperlipoproteinemia Type IV (Elevated VLDL), Hyperlipoproteinemia Type V (Elevated Chylomicrons + VLDL)

Health Tip: What's Behind High Cholesterol?

Posted 12 days ago by Drugs.com

-- High cholesterol is a risk factor for serious health problems, from heart attack to stroke. The National Heart Lung and Blood Institute mentions these possible causes: Eating a diet high in cholesterol-rich foods, such as meat, cheese, egg yolks and other animal products. Foods high in saturated and trans fats also increase cholesterol. Being overweight or lack of physical activity can lead to extra pounds and boost cholesterol. Being age 55 or older increases your risk of high cholesterol. Having an inherited condition called familial cholesterolemia leads to high cholesterol. Read more

Related support groups: Obesity, High Cholesterol, Hypertriglyceridemia, High Cholesterol - Familial Heterozygous, High Cholesterol - Familial Homozygous, Hyperlipoproteinemia Type IIa (Elevated LDL), Hyperlipoproteinemia, Hyperlipoproteinemia Type IIb (Elevated LDL + VLDL), Hyperlipoproteinemia Type V (Elevated Chylomicrons + VLDL), Hyperlipoproteinemia Type III (Elevated beta-VLDL + IDL), Hyperlipoproteinemia Type IV (Elevated VLDL)

Can U.S. Health-Care System Afford New, Improved Cholesterol Drugs?

Posted 18 days ago by Drugs.com

THURSDAY, June 18, 2015 – A new class of powerful cholesterol drugs is poised to hit the market, and doctors are both hopeful about their potential, and worried that insurers won't pay for them. The drugs, known as PCSK9 inhibitors, can drastically cut LDL cholesterol – the "bad" kind linked to increased risks of heart attack and stroke. And they are expected to open up a new option for people who cannot take statins, the drugs that have been the standard for cholesterol-lowering since the 1980s. Last week, an advisory panel to the U.S. Food and Drug Administration recommended the agency approve two PCSK9 inhibitors: alirocumab (Praluent) and evolocumab (Repatha). The FDA, which usually follows the recommendations of its advisory panels, is expected to OK both drugs. Some cardiologists have heralded PCSK9 inhibitors as a breakthrough – particularly for patients who can't take statins ... Read more

Related support groups: High Cholesterol, Lipitor, Simvastatin, Crestor, Pravastatin, Atorvastatin, Zocor, Lovastatin, Zetia, Rosuvastatin, Hypertriglyceridemia, Red Yeast Rice, High Cholesterol - Familial Heterozygous, Livalo, Pravachol, High Cholesterol - Familial Homozygous, Ezetimibe, Hyperlipoproteinemia Type IIa (Elevated LDL), Hyperlipoproteinemia, Lescol

FDA Advisers Weigh 2 New Cholesterol Drugs

Posted 9 Jun 2015 by Drugs.com

TUESDAY, June 9, 2015 – U.S. health experts are weighing whether to endorse two drugs from a new class of cholesterol medications that seem to sharply cut "bad" LDL cholesterol in people who don't fare well on the commonly used drugs called statins. The new drugs are known as PCSK9 inhibitors. U.S. Food and Drug Administration advisers are meeting Tuesday and Wednesday to discuss and possibly recommend approval of the drugs alirocumab (Praluent) and evolocumab (Repatha). While the FDA isn't compelled to follow the recommendations of its advisory committees, it usually does so. A recent review of 24 clinical trials – published April 28 in the Annals of Internal Medicine – found that PCSK9 inhibitors lowered people's LDL cholesterol by about 47 percent, on average. More important, the drugs seemed to cut the risk of heart attack or death from heart disease, according to the ... Read more

Related support groups: High Cholesterol, Lipitor, Simvastatin, Crestor, Pravastatin, Atorvastatin, Zocor, Lovastatin, Rosuvastatin, Red Yeast Rice, Livalo, Pravachol, Hyperlipoproteinemia Type IIa (Elevated LDL), Hyperlipoproteinemia, Lescol, Hyperlipoproteinemia Type IIb (Elevated LDL + VLDL), Lescol XL, Mevacor, Pitavastatin, Fluvastatin

Statins Pose No Greater Harm to Memory, Study Suggests

Posted 8 Jun 2015 by Drugs.com

MONDAY, June 8, 2015 – Even though some early research suggested that people who take statin drugs might experience short-term memory loss, a large new study finds they are no worse for recall than other cholesterol-lowering medications. According to researchers at Rutgers University in New Jersey and the University of Pennsylvania, prior, limited research and anecdotal information from patients had hinted that statins might cause memory problems – leading some patients to stop taking the drugs. Statins include widely used medications such as Crestor, Lipitor and Zocor. To investigate the issue, a team led by Brian Strom, chancellor of Biomedical and Health Sciences at Rutgers, analyzed data from nearly 1 million patients. The researchers compared memory changes in three groups: Patients who recently started taking statins, those taking other cholesterol-lowering drugs, and people not ... Read more

Related support groups: High Cholesterol, Lipitor, Simvastatin, Crestor, Pravastatin, Atorvastatin, Zocor, Lovastatin, Rosuvastatin, Red Yeast Rice, Livalo, Mild Cognitive Impairment, Pravachol, Hyperlipoproteinemia, Lescol, Lescol XL, Mevacor, Altoprev, Pitavastatin, Fluvastatin

Cholesterol Drugs May Lower Stroke Risk for Healthy Older Adults

Posted 19 May 2015 by Drugs.com

TUESDAY, May 19, 2015 – Healthy older adults who take cholesterol-lowering drugs may be cutting their risk of stroke, a new French study suggests. The study found that when people took medications called statins or fibrates, their risk of stroke over almost a decade went down by about one-third. But, lead researcher Dr. Christophe Tzourio, a professor of epidemiology at the University of Bordeaux and Inserm in France, doesn't think older people should start taking these drugs solely for stroke prevention. "Our results should not be interpreted as an indication for prescribing statins or fibrates to elderly individuals. We wouldn't recommend changing medications based on the results of only one study," he said. "The next step is to see whether we can replicate our findings or not," he added. The report was published May 19 in the BMJ. Statins include drugs such as Lipitor and Zocor. ... Read more

Related support groups: Ischemic Stroke, High Cholesterol, Lipitor, Simvastatin, Crestor, Pravastatin, Atorvastatin, Zocor, Lovastatin, Transient Ischemic Attack, Tricor, Rosuvastatin, Hypertriglyceridemia, Red Yeast Rice, High Cholesterol - Familial Heterozygous, Livalo, Ischemic Stroke - Prophylaxis, Pravachol, High Cholesterol - Familial Homozygous, Thromboembolic Stroke Prophylaxis

One-Third of Americans Have Dangerous Mix of Heart Risk Factors

Posted 19 May 2015 by Drugs.com

TUESDAY, May 19, 2015 – More than one-third of U.S. adults have a combination of health problems collectively known as metabolic syndrome that increase the risk of heart disease and diabetes, according to new research. What's worse, the researchers found the rate of metabolic syndrome increases dramatically with age. Almost half of people 60 or older in the United States have metabolic syndrome, the study found. "That's concerning, because we know the population of the U.S. is aging," said senior author Dr. Robert Wong, an assistant clinical professor at University of California, San Francisco. "I think it will potentially place a huge burden on our health care system." Metabolic syndrome is a "perfect storm" of conditions that include high blood pressure, abnormal cholesterol levels, increased levels of blood sugar, and a wider waist circumference, Wong said. Medical experts are ... Read more

Related support groups: High Blood Pressure, Diabetes, Type 2, Hypertension, Heart Disease, High Cholesterol, Lipitor, Simvastatin, Crestor, Pravastatin, Atorvastatin, Niacin, Angina, Zocor, Niaspan, Lovastatin, Insulin Resistance, Pre-Diabetes, Vytorin, Rosuvastatin, Hypertriglyceridemia

Staying Fit May Delay Onset of High Cholesterol, Study Finds

Posted 11 May 2015 by Drugs.com

MONDAY, May 11, 2015 – Men who keep fit may find they delay normal age-related increases in blood cholesterol levels by up to 15 years, a new study suggests. It is common for cholesterol levels to rise with age and then decrease later in life, the study authors explained in background notes. Previous studies have shown that high cholesterol levels can be a risk factor for heart disease. Regular physical activity can lower this risk, the researchers said. "Exercise and being fit helps keep arteries clear by lowering 'bad' [LDL] cholesterol and boosting 'good' [HDL] cholesterol," explained study author Dr. Xuemei Sui, an assistant professor at the Arnold School of Public Health at the University of South Carolina in Columbia, S.C. "It also reduces other risk factors for atherosclerosis [narrowed arteries] and blood clots, such as high blood pressure, diabetes, obesity and stress," Sui ... Read more

Related support groups: High Cholesterol, Lipitor, Simvastatin, Crestor, Pravastatin, Atorvastatin, Zocor, Lovastatin, Zetia, Rosuvastatin, Hypertriglyceridemia, Red Yeast Rice, High Cholesterol - Familial Heterozygous, Livalo, Pravachol, High Cholesterol - Familial Homozygous, Ezetimibe, Hyperlipoproteinemia Type IIa (Elevated LDL), Hyperlipoproteinemia, Lescol

Americans' Blood Triglyceride Levels Dropping: CDC

Posted 7 May 2015 by Drugs.com

THURSDAY, May 7, 2015 – Americans' levels of triglycerides – a type of fat in the blood – have dropped significantly in the past decade, according to a new federal study. Factors that may lower triglyceride levels include quitting smoking, weight loss, use of cholesterol-lowering drugs (such as statins) and improving dietary nutrition, the researchers said. "The news is encouraging," said Dr. Michael Miller, a professor at the University of Maryland School of Medicine in Baltimore. But Miller, who was not involved with the study, added that it is "certainly nothing to brag about when one out of every three middle-aged men 40 to 59, and nearly one out of every three women aged 60 and over continue to live with unhealthy triglyceride levels." Like the bad type of cholesterol – LDL – high levels of triglycerides raise the risk of clogged arteries and heart disease. Another expert, Dr. ... Read more

Related support groups: High Cholesterol, Lipitor, Simvastatin, Crestor, Pravastatin, Atorvastatin, Zocor, Lovastatin, Rosuvastatin, Hypertriglyceridemia, Red Yeast Rice, High Cholesterol - Familial Heterozygous, Livalo, Pravachol, High Cholesterol - Familial Homozygous, Hyperlipoproteinemia Type IIa (Elevated LDL), Hyperlipoproteinemia, Lescol, Lescol XL, Mevacor

Many Aging Boomers Face Chronic Illness, But Death Rate Is Falling: CDC

Posted 6 May 2015 by Drugs.com

WEDNESDAY, May 6, 2015 – A new study finds mixed results for the health of America's aging "Baby Boom" generation, with nearly half of people ages 55 to 64 taking a prescription heart drug and about 1 in 5 dealing with diabetes. However, the report from the U.S. Centers for Disease Control and Prevention also finds that the overall death rate in this age group has gone down over the past decade. The report shows that the "prevalence of diabetes and obesity among Baby Boomers remains remarkably high and is a public health concern," said Dr. Ronald Tamler, who directs the Mount Sinai Clinical Diabetes Institute in New York City. But he said the new findings also show that "interventions focusing on heart health are beginning to pay off." The new data comes from an annual report from the CDC's National Center for Health Statistics, looking at 2014 statistics on the health of all ... Read more

Related support groups: High Blood Pressure, Diabetes, Type 2, Hypertension, Heart Disease, High Cholesterol, Heart Attack, Heart Failure, Congestive Heart Failure, Angina, Insulin Resistance, Pre-Diabetes, Myocardial Infarction, Hypertriglyceridemia, Left Ventricular Dysfunction, Diabetes Mellitus, Cardiovascular Risk Reduction, Hyperlipoproteinemia, Myocardial Infarction - Prophylaxis, Abnormal Glucose Tolerance, Hypertensive Heart Disease

How to Lower Your Stroke Risk

Posted 1 May 2015 by Drugs.com

FRIDAY, May 1, 2015 – There are a number of ways you can reduce your risk of stroke, a neurologist says. "Stroke is the fifth leading cause of death in the United States, and a leading cause of disability," Dr. Jose Biller, chair of Illinois-based Loyola University's department of neurology, said in a university news release. "Stroke can happen to anyone at any age." Stroke risk is increased by lifestyle factors such as smoking, drinking, high blood pressure, high cholesterol, diabetes, obesity, as well as certain heart conditions and mini-strokes (called "transient ischemic attacks"). When a stroke occurs, brain cells begin to die. That means it's critically important to be able to recognize the signs of stroke and call 911 immediately. "Time is brain. Prompt treatment potentially can reduce stroke damage significantly," Biller said. A system called FAST can help you recognize stroke ... Read more

Related support groups: High Blood Pressure, Diabetes, Type 2, Hypertension, Smoking, High Cholesterol, Smoking Cessation, Transient Ischemic Attack, Ischemic Stroke - Prophylaxis, Hyperlipoproteinemia, Hypertensive Heart Disease

New Guidelines Would Greatly Boost Number of Young People on Statins

Posted 6 Apr 2015 by Drugs.com

MONDAY, April 6, 2015 – If all doctors followed new cholesterol guidelines aimed at children, almost half a million Americans aged 17 to 21 would be prescribed a cholesterol-lowering statin drug, a new study predicts. In 2011, the U.S. National Heart, Lung, and Blood Institute (NHLBI) issued new guidelines on reducing heart disease in adolescents and young adults. Those guidelines recommended that all people aged 17 to 21 get their blood levels of cholesterol checked, and statin treatment be initiated if cholesterol was at a certain level. In contrast, the American College of Cardiology (ACC) and American Heart Association (AHA) are sticking by adult-focused guidelines that more tightly restrict the use of statins for those under 40 years age. In the new study, researchers led by Dr. Holly Gooding of Boston Children's Hospital looked at data from more than 6,300 participants, aged 17 ... Read more

Related support groups: High Cholesterol, Hypertriglyceridemia, High Cholesterol - Familial Heterozygous, High Cholesterol - Familial Homozygous, Hyperlipoproteinemia Type IIa (Elevated LDL), Hyperlipoproteinemia, Hyperlipoproteinemia Type IIb (Elevated LDL + VLDL), Hyperlipoproteinemia Type III (Elevated beta-VLDL + IDL), Hyperlipoproteinemia Type IV (Elevated VLDL), Hyperlipoproteinemia Type V (Elevated Chylomicrons + VLDL)

Poor Response to Statins May Mean Clogged Arteries

Posted 26 Feb 2015 by Drugs.com

THURSDAY, Feb. 26, 2015 – Twenty percent of people with heart disease don't respond to cholesterol-lowering statins and may have dangerously clogged arteries, researchers have found. A new study found these people experienced little or no reduction in the "bad" cholesterol that contributes to artery-blocking plaque, making heart attack or stroke more likely. The finding has important implications for statin guidelines, said lead researcher Dr. Stephen Nicholls, deputy director of the South Australian Health & Medical Research Institute in Adelaide. "Cholesterol levels should continue to be monitored to ensure we are moving in the right direction," said Nicholls. "It is simply not good enough to prescribe [a statin] and move on." The analysis also underscores the need for new medications to target plaque buildup in statin nonresponders, the study said. Nicholls said many patients – ... Read more

Related support groups: High Cholesterol, Lipitor, Simvastatin, Crestor, Pravastatin, Atorvastatin, Zocor, Lovastatin, Rosuvastatin, Red Yeast Rice, Livalo, Pravachol, Cardiovascular Risk Reduction, Hyperlipoproteinemia, Lescol, Lescol XL, Mevacor, Altoprev, Fluvastatin, Baycol

For Cholesterol Control, Experts Urge More Than Meds

Posted 29 Dec 2010 by Drugs.com

TUESDAY, Dec. 28 – Advances in medical science have made it easier than ever to lower dangerous cholesterol levels. A class of cholesterol-lowering drugs known as statins have proven particularly effective, reducing the risk for heart-related death by as much as 40 percent in people who have already suffered a heart attack, said Dr. Vincent Bufalino, president and chief executive of Midwest Heart Specialists and a spokesman for the American Heart Association. "People have said we need them in the drinking water because they are just so effective in lowering cholesterol," Bufalino said. But he and other doctors warn that when it comes to controlling cholesterol and enjoying overall health, nothing beats lifestyle changes, such as a heart-friendly diet and regular exercise. "Once we became a fast-food generation, it's just too easy to order it at the first window, pick it up at the ... Read more

Related support groups: High Cholesterol, Hypertriglyceridemia, High Cholesterol - Familial Heterozygous, High Cholesterol - Familial Homozygous, Hyperlipoproteinemia Type IIa (Elevated LDL), Hyperlipoproteinemia, Hyperlipoproteinemia Type IIb (Elevated LDL + VLDL), Hyperlipoproteinemia Type III (Elevated beta-VLDL + IDL), Hyperlipoproteinemia Type IV (Elevated VLDL), Hyperlipoproteinemia Type V (Elevated Chylomicrons + VLDL)

Ask a Question

Further Information

Related Condition Support Groups

Hyperlipoproteinemia Type IIa (Elevated LDL), Hyperlipoproteinemia Type IIb (Elevated LDL + VLDL), Hyperlipoproteinemia Type IV (Elevated VLDL), Hyperlipoproteinemia Type V (Elevated Chylomicrons + VLDL), Hyperlipoproteinemia Type III (Elevated beta-VLDL + IDL), High Cholesterol

Related Drug Support Groups

Lipitor, simvastatin, Crestor, pravastatin, atorvastatin, niacin, Welchol, Zocor, fenofibrate, view more... Niaspan, lovastatin, cholestyramine, Tricor, gemfibrozil, rosuvastatin, Questran, Prevalite, Pravachol, Lopid, colestipol, Simcor, Slo-Niacin, Antara, colesevelam, Cholestyramine Light, Lipofen, Lescol, Colestid, Advicor, Lofibra, Lescol XL, Questran Light, Mevacor, Fenoglide, Triglide, fluvastatin, Nicotinic Acid, Altoprev, Lipidil Micro, Colestid Flavored, Locholest, Nicotinex, Lipidil EZ, Lipidil Supra, Nicolar, Altocor, Niacor, lovastatin / niacin, niacin / simvastatin, Nicobid Tempules, B-3-50, Niacin SR, Niacor B3, B3-500-Gr, Nico-400